Chemoinformaics analysis of 5,9,12-Octadecatrienoic acid
Molecular Weight | 278.436 | nRot | 13 |
Heavy Atom Molecular Weight | 248.196 | nRig | 4 |
Exact Molecular Weight | 278.225 | nRing | 0 |
Solubility: LogS | -4.064 | nHRing | 0 |
Solubility: LogP | 5.228 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 51.6678 |
nHD | 1 | BPOL | 30.9642 |
QED | 0.348 |
Synth | 2.611 |
Natural Product Likeliness | 1.329 |
NR-PPAR-gamma | 0.963 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0.001 |
HIA | 0.055 |
CACO-2 | -5.181 |
MDCK | 0.0000314 |
BBB | 0.002 |
PPB | 1.0042 |
VDSS | 0.313 |
FU | 0.007 |
CYP1A2-inh | 0.142 |
CYP1A2-sub | 0.187 |
CYP2c19-inh | 0.044 |
CYP2c19-sub | 0.064 |
CYP2c9-inh | 0.275 |
CYP2c9-sub | 0.996 |
CYP2d6-inh | 0.211 |
CYP2d6-sub | 0.826 |
CYP3a4-inh | 0.074 |
CYP3a4-sub | 0.023 |
CL | 1.738 |
T12 | 0.895 |
hERG | 0.028 |
Ames | 0.001 |
ROA | 0.003 |
SkinSen | 0.953 |
Carcinogencity | 0.037 |
EI | 0.968 |
Respiratory | 0.176 |
NR-Aromatase | 0.06 |
Antiviral | Yes |
Prediction | 0.586874 |